Table 1.
Stepwise conditional logistic regression analysis of HLA-B allelic associations with ankylosing spondylitis in the Turkish and Iranian cohorts.
Table 2.
Genome-wide significant and suggestive non-MHC loci for ankylosing spondylitis in the Turkish cohort.
Table 3.
Genome-wide significant and suggestive non-MHC loci for ankylosing spondylitis in the Iranian cohort.
Table 4.
Genome-wide significant and suggestive non-MHC loci for AS in the meta-analysis of both Iranian and Turkish cohorts.
The loci in italics were in the known 113 loci.
Table 5.
Comparison of MEFV M694V in Turkish, Iranian and the meta-analysis of both cohorts.
Table 6.
Genotype counts and (%) of rs61752717 in HLA-B27-positive and HLA-B27-negative Turkish cohorts (including four HLA-B27-negative subjects with co-existent AS and FMF, three homozygous for rs61752717 ‘C’ allele, one homozygote for rs61752717 ‘T’ allele).
Table 7.
Genotype counts and (%) of rs61752717 in HLA-B27-positive and HLA-B27-negative combined cohorts (including four HLA-B27-negative subjects with co-existent AS and FMF, three homozygous for rs61752717 ‘C’ allele, one homozygote for rs61752717 ‘T’ allele).
Table 8.
Genotype counts and (%) of rs61752717 in HLA-B27-positive and HLA-B27-negative Iranian cohorts.
Table 9.
Serum cytokine levels by case or control status and MEFV M694V carrier status.